<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Reprod Dev</journal-id><journal-id journal-id-type="iso-abbrev">J. Reprod. Dev</journal-id><journal-id journal-id-type="publisher-id">JRD</journal-id><journal-title-group><journal-title>The Journal of Reproduction and Development</journal-title></journal-title-group><issn pub-type="ppub">0916-8818</issn><issn pub-type="epub">1348-4400</issn><publisher><publisher-name>The Society for Reproduction and Development</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23449310</article-id><article-id pub-id-type="pmc">3934129</article-id><article-id pub-id-type="publisher-id">2013-001</article-id><article-id pub-id-type="doi">10.1262/jrd.2013-001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Functional Analysis of Nocturnin, a Circadian Deadenylase, at
Maternal-to-zygotic Transition in Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>NISHIKAWA</surname><given-names>Satoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>HATANAKA</surname><given-names>Yuki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>TOKORO</surname><given-names>Mikiko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>SHIN</surname><given-names>Seung-Wook</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>SHIMIZU</surname><given-names>Natsumi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>NISHIHARA</surname><given-names>Takuji</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>KATO</surname><given-names>Rie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>TAKEMOTO</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>AMANO</surname><given-names>Tomoko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>ANZAI</surname><given-names>Masayuki</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>KISHIGAMI</surname><given-names>Satoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>HOSOI</surname><given-names>Yoshihiko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>MATSUMOTO</surname><given-names>Kazuya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label>1)</label>Laboratory of Molecular Developmental Biology, Graduate
School of Biology-Oriented Science and Technology, Kinki University, Wakayama 649-6493,
Japan</aff><aff id="aff2"><label>2)</label>Institute of Advanced Technology, Kinki University, Wakayama
642-0017, Japan</aff></contrib-group><author-notes><corresp>Correspondence: K Mastumoto (e-mail: <email xlink:href="kazum@waka.kindai.ac.jp">kazum@waka.kindai.ac.jp</email>)</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>3</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2013</year></pub-date><volume>59</volume><issue>3</issue><fpage>258</fpage><lpage>265</lpage><history><date date-type="received"><day>07</day><month>1</month><year>2013</year></date><date date-type="accepted"><day>16</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9;2013 Society for Reproduction and Development</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><title>Abstract </title><p> Degradation of maternally stored mRNAs after fertilization is an essential process for
mammalian embryogenesis. Maternal mRNA degradation depending on deadenylases in mammalian
early embryos has been mostly speculated, rather than directly demonstrated. Previously,
we found that gene expression of <italic>nocturnin</italic>, which functions as a
circadian clock-controlled deadenylase in mammalian cells, was clearly changed during the
maternal-to-zygotic transition (MZT). Here, we investigated the possible role of nocturnin
during mouse MZT. First, we examined the expression profile and localization of nocturnin
in mouse oocytes and early embryos. The abundance of <italic>Nocturnin</italic> mRNA level
was significantly decreased from the MII to 4-cell stages and slightly increased from the
8-cell to blastocyst stages, whereas the Nocturnin protein level was almost stable in all
examined cells including GV and MII oocytes and early embryos. Nocturnin was localized in
both the cytoplasm and the nucleus of all examined cells. We then examined the effect of
loss or gain of <italic>Nocturnin</italic> function on early embryonic development.
Knockdown of <italic>Nocturnin</italic> by injection of <italic>Nocturnin</italic>
antisense expression vector into 1-cell embryos resulted in the delay of early embryonic
development to the early blastocyst stage. Moreover,
<italic>Nocturnin-</italic>overexpressed embryos by injection of
<italic>Nocturnin</italic> expression vector impaired their development from the 1-cell
to 2-cell or 4-cell stages. These results suggest that precise expression of nocturnin is
critical to proper development of early mouse embryos. Functional analysis of nocturnin
may contribute to the understanding of the possible role of the deadenylase at mouse
MZT.</p></abstract><kwd-group><kwd>Deadenylase</kwd><kwd>Early embryonic development</kwd><kwd>Mouse</kwd><kwd>Nocturnin</kwd></kwd-group></article-meta></front><body><p>Maternal-to-zygotic transition (MZT) is an essential process for erasure of the oogenic
program by establishing the embryonic program in totipotent zygotes [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r2" ref-type="bibr">2</xref>]. MZT is regulated by maternally
inherited transcripts and proteins that have been accumulated in the oocyte and activation of
the embryonic genome [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r4" ref-type="bibr">4</xref>]. In mice, maternal mRNA and proteins stored in ovulated oocytes with a
transcriptionally quiescent state are immediately degraded after fertilization, and a large
number of them are degraded by the 2-cell stage, which is when major zygotic gene activation
(ZGA) occurs.</p><p>The ubiquitin-proteasome system (UPS), which is involved in oocyte meiosis resumption,
spindle assembly and polar body emission [<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>], has a key role
in the degradation of stored maternal proteins after fertilization [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref>]. Moreover, a zygote-specific UPS
pathway mediated by ZPAC protein, which we have recently identified as a zygote-specific
proteasome chaperone, is important for removal of maternal proteins in mouse MZT [<xref rid="r10" ref-type="bibr">10</xref>]. Meanwhile, the molecular mechanisms underlying the
degradation of stored maternal mRNAs in zygotes are not well understood. In fact, microRNAs,
which are necessary for destabilization of mRNAs, are not essential during preimplantation
embryonic development [<xref rid="r11" ref-type="bibr">11</xref>].</p><p>In mammalian cells, changes in mRNA poly(A) tail length are linked to the regulation of mRNA
stabilization, translation and localization [<xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r13" ref-type="bibr">13</xref>]. In particular, the first step of mRNA degradation is
the poly(A) tail-shortening process, referred to as deadenylation. Deadenylation-dependent
mRNA degradation is the major pathway in mammalian cells. One or a combination of many
deadenylases including POP2 (also known as CAF1), CAF1Z, poly(A)-specific ribonuclease (PARN),
PAN2, CCR4, Nocturnin (also known as Ccrn4l), ANGEL and 2'PDE families facilitates this
process in mammalian cells [<xref rid="r12" ref-type="bibr">12</xref>]. Although the
occurrence of mRNA deadenylation during maternal mRNA degradation has been directly
demonstrated in Xenopus [<xref rid="r14" ref-type="bibr">14</xref>] and Drosophila embryos
[<xref rid="r15" ref-type="bibr">15</xref>, <xref rid="r16" ref-type="bibr">16</xref>], the
dependence of maternal mRNA degradation on deadenylases in mammalian oocytes has been mostly
inferred, rather than explicitly assessed.</p><p>We have previously performed mRNA differential display analysis to compare embryos at the
late 1-cell stage with oocytes at the MII stage in order to understand the mechanisms
governing the transition of oocytes into totipotent zygotes during the mouse MZT [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r18" ref-type="bibr">18</xref>]. In line with this, we found that
<italic>Nocturnin</italic> gene expression changed during the mouse MZT. Interestingly,
nocturnin in mammalian cells has been shown to be a clock-controlled deadenylase [<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. Thus, we
focused our attention on the role of nocturnin in mouse oocytes and early embryos. Herein, we
show that that the <italic>Nocturnin</italic> mRNA level in oocytes drastically decreased
after fertilization until the late 2-cell stage, although the Nocturnin protein level remained
mostly stable during preimplantation development. Furthermore, <italic>Nocturnin</italic>
knockdown seemed to be the cause of delayed early embryonic development to the blastocyst
stage, whereas <italic>Nocturnin</italic>-overexpressed embryos were severely impaired in
their development after the 2-cell stage. These findings support the possible role of
nocturnin during the mouse MZT.</p><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Animals</title><p>All mice (ICR) were purchased from Kiwa Experimental Animals (Wakayama, Japan) and
maintained in light-controlled, air-conditioned rooms. This study was carried out in
strict accordance with the recommendations in the Guidelines of Kinki University for the
Care and Use of Laboratory Animals. The protocol was approved by the Committee on the
Ethics of Animal Experiments of Kinki University. All mice were sacrificed by cervical
dislocation, and all efforts were made in order to minimize suffering and to reduce the
number of animals used in the present study.</p></sec><sec><title>Collection of oocytes, in vitro fertilization (IVF) and embryo culture</title><p>Collection of oocytes, IVF and embryo culture were performed according to previously
described procedures [<xref rid="r18" ref-type="bibr">18</xref>]. In brief, spermatozoa
were collected from the cauda epididymis of a male mouse. The sperm suspension was
incubated for 1.5 h to allow for capacitation at 37 C under 5% CO<sub>2</sub> in air.
Oocytes were collected from the excised oviducts of female mice (2&#x02013;3 months old) that had
been superovulated with pregnant mare serum gonadotropin (PMSG; PEAMEX, ZENOAQ, Fukushima,
Japan) followed 48 h later by treatment with human chorionic gonadotropin (hCG:
Gonatropin, ASKA Pharmaceutical, Tokyo, Japan). Cumulus-oocyte complexes were recovered in
a pre-equilibrated HTF medium. The sperm suspension was added to the oocyte-containing
medium. Morphologically normal fertilized oocytes with a second polar body were collected
from the sperm suspension 1 h after insemination. The eggs were cultured in a K-SOM medium
at 37 C under 5% CO<sub>2</sub> in air [<xref rid="r21" ref-type="bibr">21</xref>]. In
addition, we only used fertilized oocytes with male and female pronuclei at 6 hours post
insemination (hpi) for further experiments.</p></sec><sec><title>Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR)
analysis</title><p>Quantitative RT-PCR analyses were performed as previously described [<xref rid="r22" ref-type="bibr">22</xref>]. In brief, total RNA was isolated from 20 pooled
oocytes or embryos by using RNAqueous-Micro Kits (Ambion, Austin, TX, USA). cDNA was
synthesized from each total RNA by using SuperScript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA, USA), respectively. Prepared cDNA samples were amplified using
the specific primers (<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title> PCR primers</title></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="1" colspan="1">Primer name</td><td align="center" rowspan="1" colspan="1">Sequences (5'&#x02013;3')</td><td align="center" rowspan="1" colspan="1">Applications</td></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Noc</italic>_F</td><td align="center" valign="middle" rowspan="1" colspan="1">ACCTGAGGACAGATTGCTCCA</td><td align="center" valign="middle" rowspan="2" colspan="1">Quantitative RT-PCR for
<italic>Noc</italic></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Noc</italic>_R</td><td align="center" valign="middle" rowspan="1" colspan="1">AGGATCAGGCACTTCCTCTCTTC</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Actin</italic>_F</td><td align="center" valign="middle" rowspan="1" colspan="1">ACCACAGTCCATGCCATCAC</td><td align="center" valign="middle" rowspan="2" colspan="1">Quantitative RT-PCR for
<italic>Actin</italic></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Actin</italic>_R</td><td align="center" valign="middle" rowspan="1" colspan="1">TCCACCACCCTGTTGCTGTA</td></tr></tbody></table></table-wrap>) and analyzed by quantitative RT-PCR. Real-Time quantitative PCR was
performed using an ABI 7300 instrument and TaqMan Gene Expression Assays (Applied
Biosystems, Foster City, CA, USA). To express the data concisely, the duplicated data were
averaged. The averaged data of the transcripts of each gene from each of three independent
samples were analyzed.</p></sec><sec><title>Generation of anti-Nocturnin antiserum</title><p>The design of peptide synthesis of Nocturnin (QSEPPYTTWKIR, residues 354-365 a.a.) was
based on the relative hydrophilicity and flexibility of regions analyzed by a computer
program (GENETYX-Mac Ver. 12.0.3, GENETYX, Tokyo, Japan). The region used as the synthetic
peptide has high hydrophilicity and no putative site of modification (data not shown).
Anti-Nocturnin antiserum was obtained by injection of the peptide&#x02013;KLH (keyhole limpet
hemocyanin) complex followed by booster injections at one-week intervals, six times in
total, into New Zealand white rabbits (Kitayama LABES, Nagano, Japan). ELISA was used to
compare the serum titer from the rabbits before and after immunization with the peptides.
Finally, anti-Nocturnin antibody was fractionated with 40% ammonium sulphate and used
throughout this study.</p></sec><sec><title>Western blot analysis</title><p>The procedures for immunoblot analysis were essentially those reported previously [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r18" ref-type="bibr">18</xref>]. In brief, in Western blot analysis, protein was
isolated from 30 embryos in each experimental group. We used the following antibodies:
anti-Nocturnin (1:300) or anti-Actin (1:7,500; Santa Cruz Biotechnology, Santa Cruz, CA,
USA; SC-1616) as a loading control. We used a goat anti-rabbit IgG HRP conjugate
(1:100,000; Millipore, Billerica, MA, USA; AP180P) and/or donkey anti-mouse IgG HRP
conjugate (1:100,000; Santa Cruz Biotechnology; A-0545) as a second antibody. As the
positive control of anti-Nocturnin antibody, the N-terminal 6xHis-tagged recombinant
Nocturnin was used. At least three independent experiments were performed for each
group.</p></sec><sec><title>Immunocytochemical analysis</title><p>Immunocytochemical analysis was performed as described previously [<xref rid="r23" ref-type="bibr">23</xref>]. In brief, oocytes and embryos were fixed in 4% PFA (Nacalai
Tesque, Kyoto, Japan) in phosphate-buffered saline (PBS) for 30 min at room temperature
and then incubated in PBS containing 0.1&#x02013;0.2% Triton X-100 (Nacalai Tesque) overnight at 4
C. The samples were treated with 1% acid tyrode in PBS for 3 min at room temperature to
remove the zona pellucida and then washed thoroughly in PBS including 0.01% polyvinyl
alcohol (PVA; Sigma-Aldrich, St. Louis, Mo, USA; P8136). Then, the samples were incubated
with anti-Nocturnin antibody (1:3,000) in PBS containing 30 mg/ml bovine serum albumin
overnight at 4 C. After incubation, the samples were reacted with Alexa Flour 594-labeled
donkey anti-rabbit IgG (Invitrogen, 1:1,000) for 1 h at room temperature. Specimens were
mounted on glass slides in a Vectashield mounting medium (Vector Laboratories, Burlingame,
CA, USA) containing 2&#x02013;5 &#x003bc;g/ml DAPI (Invitrogen). The fluorescence images of oocytes and
embryos were obtained using a fluorescence microscope (BIOREVO BZ-9000; KEYENCE, Tokyo,
Japan). Three independent experiments were performed.</p></sec><sec><title>Microinjection of Nocturnin antisense or sense expression vectors</title><p>The procedure for microinjection of expression vectors was essentially as described
previously [<xref rid="r10" ref-type="bibr">10</xref>]. We subcloned full-length
<italic>Noc</italic> cDNA from an ovary cDNA library using pGEM T-easy vector (Epicentre
Technologies, Madison, WI, USA). To investigate the effects of knockdown or overexpression
of <italic>Nocturnin</italic> on the development of early embryos,
<italic>Nocturnin</italic> antisense expression vector
(p<italic>&#x003b2;</italic>&#x02013;<italic>actin promoter/antisense Nocturnin/IRES/luc+/SV40</italic>)
with bicistronic expression of both <italic>Nocturnin</italic> antisense RNA and humanized
firefly codon-optimized <italic>luciferase</italic> (<italic>luc+</italic>) gene or
Nocturnin expression vector (p<italic>&#x003b2;</italic>&#x02013;<italic>actin promoter/sense
Nocturnin/IRES/luc+/SV40</italic>) with bicistronic expression of both
<italic>Nocturnin</italic> cDNA and humanized firefly codon-optimized
<italic>luciferase</italic> (<italic>luc+</italic>) gene was injected into the
pronucleus of zygotes at 6 to 8 hpi. The injected zygotes showing luciferase activity at
16 h after microinjection were selected and then cultured to examine the effect of
antisense <italic>Nocturnin</italic> expression or the effect of
<italic>Nocturnin</italic> expression on subsequent embryonic development to blastocyst
stage. In these experiments, p<italic>&#x003b2;</italic>&#x02013;<italic>actin
promoter/IRES/luc+/SV40</italic> was used as a control expression vector.</p></sec><sec><title>Statistical analysis</title><p>For statistical analysis, we used StatView version 5.0 (SAS Institute, Cary, NC, USA) and
Microsoft Excel, and performed analysis of variance (ANOVA) with an &#x003b1; level of 0.05 to
determine possible statistically significant differences between group means.</p></sec></sec><sec sec-type="results" id="s2"><title>Results</title><sec><title>Expression of nocturnin during MZT</title><p>Since the <italic>Nocturnin</italic> gene was predicted to be maternally expressed in
early mouse embryos according to its EST profile described in the UniGene database, we
examined gene expression profiles and subcellular localization of nocturnin during early
mouse embryogenesis. In early mouse embryos, the <italic>Nocturnin</italic> gene showed a
unique maternal gene expression profile. The amount of <italic>Nocturnin</italic> mRNA,
which was highest in oocytes, began to decrease after fertilization by the 4-cell stage
and then slightly increased up to the blastocyst stage (<xref ref-type="fig" rid="fig_001">Fig. 1A</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p> Expression profiles of nocturnin in mouse early embryos. A: Quantitative RT-PCR
for the expression profile of <italic>Nocturnin</italic> mRNA in mouse oocytes and
early mouse embryos. Different lowercase letters indicate statistical significance
(P <italic>&#x0003c;</italic>0.05). <italic>Actin</italic> was used as a control. B, C:
Immunoblot analysis for the expression profile of Nocturnin protein in mouse oocytes
and early embryos. Different lowercase letters indicate statistical significance (P
<italic>&#x0003c;</italic>0.05). <italic>Actin</italic> was used as a loading control.
Moreover, 6xHis-tagged recombinant Nocturnin was used as positive control for
Nocturnin antibody. The experiments were performed three times. Different
superscripts indicate statistical differences (P <italic>&#x0003c;</italic>0.05).</p></caption><graphic xlink:href="jrd-59-258-g001"/></fig>). However, the abundance of Nocturnin protein was maintained during preimplantation
development, even after its mRNA level was markedly decreased (<xref ref-type="fig" rid="fig_001">Fig. 1B, C</xref>), suggesting posttranscriptional regulation of
<italic>Nocturnin</italic> gene expression. Consistent with the immunoblot analysis,
intense signals of Nocturnin protein were diffusely detected in the cytoplasm and nucleus
at all embryonic developmental stages (<xref ref-type="fig" rid="fig_002">Fig.
2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p> Subcellular localization of Nocturnin in mouse oocytes and early mouse embryos.
Subcellular localization of Nocturnin was observed during mouse preimplantation
embryo development. Scale bars represent 20 &#x003bc;m.</p></caption><graphic xlink:href="jrd-59-258-g002"/></fig>). As development proceeded, the Nocturnin signals, which decreased at the 4-cell
stage, were clearly detectable at the 8-cell stage. Taken together, these results raise
the possibility that nocturnin is functioning in the cytoplasm and nucleus during the MZT
of early mouse embryos.</p></sec><sec><title>Effect of Nocturnin loss of function on early mouse embryonic development</title><p>In order to clarify the role of nocturnin in the development of early mouse embryos,
<italic>Nocturnin</italic> knockdown embryos were generated by pronuclei injection of
<italic>Nocturnin</italic> antisense DNA with internal ribosomal entry sites
(IRES)-<italic>luciferase</italic> as a marker for successful expression (<xref ref-type="fig" rid="fig_003">Fig. 3A</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p> Nocturnin knockdown embryos showed delayed early embryo development. A: Schematic
diagram of experiments using fertilized oocytes injected with control expression
vector (p<italic>&#x003b2;</italic>&#x02013;<italic>actin promoter/IRES/luc+/SV40)</italic> or
<italic>Nocturnin</italic> antisense expression vector
(p<italic>&#x003b2;</italic>&#x02013;<italic>actin promoter/antisense
Nocturnin/IRES/luc+/SV40</italic>) from 6&#x02013;8 hpi. B, C:
<italic>Nocturnin</italic>-knockdown by a <italic>Nocturnin</italic> antisense
expression vector was confirmed by immunoblot analysis. Actin was used as a control.
The experiments were performed three times. D: Effect of <italic>Nocturnin</italic>
knockdown on the development of early mouse embryos. An asterisk indicates that the
value is statistically different (P <italic>&#x0003c;</italic>0.05).</p></caption><graphic xlink:href="jrd-59-258-g003"/></fig>). At 24 hpi, immunoblot analysis revealed more than 61% loss of Nocturnin proteins
in the embryos showing luciferase expression that were injected with
<italic>Nocturnin</italic> antisense DNA (arrested 1-cell embryos <italic>vs.</italic>
control, 0.39 &#x000b1; 0.04 <italic>vs.</italic> 1.00 &#x000b1; 0.1, P &#x0003c;0.05; early 2-cell embryos
<italic>vs.</italic> control, 0.25 &#x000b1; 0.06 <italic>vs.</italic> 1.00 &#x000b1; 0.1, P &#x0003c;0.05;
ave. &#x000b1; S.E.) (<xref ref-type="fig" rid="fig_003">Fig. 3B and 3C</xref>, left). Also, at 36
hpi more than 70% reduction of Nocturnin proteins was found in the
<italic>Nocturnin</italic> antisense DNA injected embryos showing the luciferase
activity (arrested 1-cell embryos <italic>vs.</italic> control, 0.16 &#x000b1; 0.06
<italic>vs.</italic> 1.00 &#x000b1; 0.17, P &#x0003c;0.05; early 2-cell embryos <italic>vs.</italic>
control, 0.31 &#x000b1; 0.1 <italic>vs.</italic> 1.00 &#x000b1; 0.17, P &#x0003c;0.05; ave. &#x000b1; S.E.) (<xref ref-type="fig" rid="fig_003">Fig. 3B and 3C</xref>, right). As shown in <xref ref-type="fig" rid="fig_003">Fig. 3D</xref>, <italic>in vitro</italic> development of
luciferase-positive embryos injected with <italic>Nocturnin</italic> antisense expression
vector to the early blastocyst stage was significantly delayed compared with that of
control embryos injected with the control expression vector (<italic>Nocturnin</italic>
knockdown embryos <italic>vs.</italic> control embryos: the early 2-cell stage at 24 hpi,
46 <italic>vs.</italic> 72%, P &#x0003c;0.05; the 4-cell stage at 48 hpi, 30
<italic>vs.</italic> 60%, P &#x0003c;0.05; the morula stage at 72 hpi, 12
<italic>vs.</italic> 47%, P &#x0003c;0.05; the early blastocyst stage at 96 hpi, 7
<italic>vs.</italic> 41%, P &#x0003c;0.05). Interestingly, it is reported that
<italic>Nocturnin</italic>-knockout mice exhibit no obvious abnormalities in development
or reproduction [<xref rid="r24" ref-type="bibr">24</xref>, <xref rid="r25" ref-type="bibr">25</xref>]. In accordance with this, the luciferase-positive
<italic>Nocturnin</italic> knockdown embryos developed to each stage (2-cell, 4-cell,
6&#x02013;8-cell, morula and blastocyst) as well as the control embryos (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title> Effect of <italic>Nocturnin</italic> knockdown on the development of early
mouse embryos</title></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="2" valign="middle" colspan="1">Injected vectors</td><td align="center" colspan="3" rowspan="1">No. (%) of embryos</td><td align="center" colspan="7" rowspan="1">No. (%) of embryos developed to</td></tr><tr><td align="center" rowspan="1" colspan="1">Injected</td><td align="center" rowspan="1" colspan="1">Survived</td><td align="center" rowspan="1" colspan="1">Expressed</td><td align="center" rowspan="1" colspan="1">1-cell</td><td align="center" rowspan="1" colspan="1">2-cell</td><td align="center" rowspan="1" colspan="1">4-cell</td><td align="center" rowspan="1" colspan="1">6 to 8-cell</td><td align="center" rowspan="1" colspan="1">Morulae</td><td align="center" rowspan="1" colspan="1">Blastocysts</td><td align="center" rowspan="1" colspan="1">Degenerated</td></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">341</td><td align="center" valign="middle" rowspan="1" colspan="1">252 (74)</td><td align="center" valign="middle" rowspan="1" colspan="1">204 (81)</td><td align="center" valign="middle" rowspan="1" colspan="1">204 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">156 (76)</td><td align="center" valign="middle" rowspan="1" colspan="1">130 (64)</td><td align="center" valign="middle" rowspan="1" colspan="1">114 (56)</td><td align="center" valign="middle" rowspan="1" colspan="1">99 (49)</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (41)</td><td align="center" valign="middle" rowspan="1" colspan="1">77 (38)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antisense <italic>Nocturnin</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">545</td><td align="center" valign="middle" rowspan="1" colspan="1">324 (59)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (27)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (69)</td><td align="center" valign="middle" rowspan="1" colspan="1">52 (59)</td><td align="center" valign="middle" rowspan="1" colspan="1">43 (49)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (38)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (32)</td><td align="center" valign="middle" rowspan="1" colspan="1">34 (39)</td></tr></tbody></table></table-wrap>).</p></sec><sec><title>Effect of Nocturnin gain of function on early mouse embryonic development</title><p>Next, we examined the effect of <italic>Nocturnin</italic> overexpression on the
development of early mouse embryo. Embryos overexpressing <italic>Nocturnin</italic> were
generated by pronuclei injection of <italic>Nocturnin</italic> cDNA with internal
ribosomal entry sites (IRES)-<italic>luciferase</italic> as a marker for successful
expression (<xref ref-type="fig" rid="fig_004">Fig. 4A</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p> Embryos with overexpression of Nocturnin were arrested at the 1-cell to 2-cell
stages. A: Schematic diagram of experiments using fertilized oocytes injected with
control expression vector (p<italic>&#x003b2;</italic>&#x02013;<italic>actin
promoter/IRES/luc+/SV40)</italic> or <italic>Nocturnin</italic> expression vector
(p<italic>&#x003b2;</italic>&#x02013;<italic>actin promoter/sense
Nocturnin/IRES/luc+/SV40</italic>) from 6&#x02013;8 hpi. B,C:
<italic>Nocturnin</italic>-overexpression by a <italic>Nocturnin</italic> expression
vector was confirmed by immunoblot analysis. Actin was used as a control. The
experiments were performed three times. D: Effect of <italic>Nocturnin</italic>
overexpression on the development of early mouse embryos. An asterisk indicates that
the value is statistically different (P <italic>&#x0003c;</italic>0.05).</p></caption><graphic xlink:href="jrd-59-258-g004"/></fig>). At 24 hpi, the amount of Nocturnin proteins was significantly increased by
approximately 336% or 320% in arrested 1-cell or early 2-cell embryos compared with that
of the control embryos, respectively (<xref ref-type="fig" rid="fig_004">Fig. 4B,
C</xref>). The majority of the luciferase-positive embryos injected with
<italic>Nocturnin</italic> expression vector were arrested at the 1-cell to 2-cell
stages, and only 4% of them developed to the 4-cell stage, whereas 61% of control embryos
developed normally to the 4-cell stage (<xref rid="tbl_003" ref-type="table">Table
3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title> Effect of <italic>Nocturnin</italic>-overexpression on the development of
early mouse embryos</title></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" rowspan="2" valign="middle" colspan="1">Injected vectors</td><td align="center" colspan="3" rowspan="1">No. (%) of embryos</td><td align="left" rowspan="2" colspan="1"/><td align="center" colspan="7" rowspan="1">No. (%) of embryos developed to</td></tr><tr><td align="center" rowspan="1" colspan="1">Injected</td><td align="center" rowspan="1" colspan="1">Survived</td><td align="center" rowspan="1" colspan="1">Expressed</td><td align="center" rowspan="1" colspan="1">1-cell</td><td align="center" rowspan="1" colspan="1">2-cell</td><td align="center" rowspan="1" colspan="1">4-cell</td><td align="center" rowspan="1" colspan="1">6 to 8-cell</td><td align="center" rowspan="1" colspan="1">Morulae</td><td align="center" rowspan="1" colspan="1">Blastocysts</td><td align="center" rowspan="1" colspan="1">Degenerated</td></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Control</td><td align="center" valign="middle" rowspan="1" colspan="1">341</td><td align="center" valign="middle" rowspan="1" colspan="1">252 (74)</td><td align="center" valign="middle" rowspan="1" colspan="1">204 (81)</td><td align="left" valign="middle" rowspan="2" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">204 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">156 (76)</td><td align="center" valign="middle" rowspan="1" colspan="1">130 (64)</td><td align="center" valign="middle" rowspan="1" colspan="1">114 (56)</td><td align="center" valign="middle" rowspan="1" colspan="1">99 (49)</td><td align="center" valign="middle" rowspan="1" colspan="1">83 (41)</td><td align="center" valign="middle" rowspan="1" colspan="1">77 (38)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sense <italic>Nocturnin</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">193</td><td align="center" valign="middle" rowspan="1" colspan="1">151 (78)</td><td align="center" valign="middle" rowspan="1" colspan="1">113 (75)</td><td align="center" valign="middle" rowspan="1" colspan="1">113 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">47 *(42)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 *(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 *(1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1* (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 *(1)</td><td align="center" valign="middle" rowspan="1" colspan="1">108 *(96)</td></tr></tbody></table><table-wrap-foot><p>* Significant difference from control (P<italic>&#x0003c;</italic>0.05).</p></table-wrap-foot></table-wrap>). Moreover, the luciferase-positive <italic>Nocturnin</italic>-overexpressed
embryos failed to develop beyond the 1-cell or 2-cell stages; only 35% and 0.6% of the
overexpressed embryos developed to the 2-cell and 4-cell stages, respectively (<xref ref-type="fig" rid="fig_004">Fig. 4D</xref>).</p></sec></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><p>In this study, we showed that the circadian deadenylase nocturnin is expressed in mouse MII
oocytes and early embryos and that precise expression of nocturnin is essential for normal
preimplantation development of embryos.</p><p>In early mammalian embryogenesis, degradation of stored maternal mRNAs and proteins is one
of the critical events that govern the MZT for embryonic development [<xref rid="r26" ref-type="bibr">26</xref>]. Also, correct regulation of the MZT is an important process for
remodeling of an oocyte into a totipotent zygote. Recently, we reported that proteasomal
degradation of maternal proteins is implicated in establishment of the embryonic program
during the MZT [<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r27" ref-type="bibr">27</xref>]. Our data may provide evidence for the possible involvement of a circadian
deadenylase, nocturnin, in maternal mRNA degradation during the mouse MZT.</p><p>Circadian genes expressed in most organs, tissues and cells encode transcription factors
that regulate the circadian clock in mammals [<xref rid="r28" ref-type="bibr">28</xref>].
<italic>Nocturnin</italic> also has rhythmic expression in multiple mouse tissues under
the control of the circadian clock [<xref rid="r29" ref-type="bibr">29</xref>]. However, we
have previously demonstrated that circadian genes in mammalian oocytes and early embryos are
not involved in the ticking of the circadian clock [<xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r28" ref-type="bibr">28</xref>]. Indeed, we observed no rhythmic
expression of the circadian deadenylase nocturnin in preimplantation embryos. Thus,
nocturnin likely plays a role as a deadenylase in early mouse embryos beyond circadian
control, although nocturnin expressed in early mouse embryos was not directly proven to
possess deadenylase activity in this study.</p><p>In the course of functional analysis by loss- and gain-of-function approaches, we noticed
that precise expression of nocturnin in early embryos is critical for normal preimplantation
development. Since it is known that there is functional redundancy among deadenylases
including nocturnin in eukaryotic cells [<xref rid="r12" ref-type="bibr">12</xref>],
moderate loss of nocturnin seems to result in delayed embryonic development. Meanwhile, the
high amount of nocturnin expression was severely harmful to early embryonic development. In
mammalian cells, nocturnin overexpression significantly increases the expression of
<italic>fatty acid-binding protein 4</italic> (<italic>ap2</italic>) and
<italic>peroxisome</italic> proliferator-activated <italic>receptor-&#x003b3;2</italic>
(<italic>PPAR-&#x003b3;2</italic>) [<xref rid="r30" ref-type="bibr">30</xref>], whether
<italic>bona fide</italic> target mRNAs directly depend on Nocturnin for deadenylation
remains unknown in early mouse embryos. Therefore, these results suggest that exogenously
overexpressed nocturnin may perturb regulated posttranscriptional expression of some target
maternal mRNAs in early mouse embryos.</p><p>Understanding the function of deadenylases including nocturnin in degradation of stored
maternal mRNAs during the mouse MZT helps to elucidate molecular mechanisms governing the
remodeling of the oocyte into a totipotent zygotes.</p></sec></body><back><ack><title>Acknowledgment</title><p>We thank N Backes-Kamimura and J Walhelm-Kimura for manuscript support and editing. This
study was supported in part by a Grant-in-Aid for the 21st Century COE Program of the
Ministry of Education, Culture, Sports, Science and Technology of Japan (to SN),
Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science
23658292 and 23380164 (to KM) and a grant from the INAMORI Foundation (to KM).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Bettegowda</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>GW</given-names></name></person-group>
<article-title>Mechanisms of maternal mRNA regulation: implications for
mammalian early embryonic development</article-title>. <source>Front
Biosci</source><year>2007</year>; <volume>12</volume>:
<fpage>3713</fpage>&#x02013;<lpage>3726</lpage>
<pub-id pub-id-type="pmid">17485333</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Stitzel</surname><given-names>ML</given-names></name><name><surname>Seydoux</surname><given-names>G</given-names></name></person-group>
<article-title>Regulation of the oocyte-to-zygote
transition</article-title>. <source>Science</source><year>2007</year>;
<volume>316</volume>: <fpage>407</fpage>&#x02013;<lpage>408</lpage>
<pub-id pub-id-type="pmid">17446393</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Schultz</surname><given-names>RM</given-names></name></person-group>
<article-title>The molecular foundations of the maternal to zygotic
transition in the preimplantation embryo</article-title>. <source>Hum Reprod
Update</source><year>2002</year>; <volume>8</volume>:
<fpage>323</fpage>&#x02013;<lpage>331</lpage>
<pub-id pub-id-type="pmid">12206467</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Minami</surname><given-names>N</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Tsukamoto</surname><given-names>S</given-names></name></person-group>
<article-title>Zygotic gene activation and maternal factors in
mammals</article-title>. <source>J Reprod Dev</source><year>2007</year>;
<volume>53</volume>: <fpage>707</fpage>&#x02013;<lpage>715</lpage>
<pub-id pub-id-type="pmid">17827882</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Huo</surname><given-names>LJ</given-names></name><name><surname>Fan</surname><given-names>HY</given-names></name><name><surname>Zhong</surname><given-names>ZS</given-names></name><name><surname>Chen</surname><given-names>DY</given-names></name><name><surname>Schatten</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>QY</given-names></name></person-group>
<article-title>Ubiquitin-proteasome pathway modulates mouse oocyte
meiotic maturation and fertilization via regulation of MAPK cascade and cyclin B1
degradation</article-title>. <source>Mech Dev</source><year>2004</year>;
<volume>121</volume>: <fpage>1275</fpage>&#x02013;<lpage>1287</lpage>
<pub-id pub-id-type="pmid">15327787</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Huo</surname><given-names>LJ</given-names></name><name><surname>Yu</surname><given-names>LZ</given-names></name><name><surname>Liang</surname><given-names>CG</given-names></name><name><surname>Fan</surname><given-names>HY</given-names></name><name><surname>Chen</surname><given-names>DY</given-names></name><name><surname>Sun</surname><given-names>QY</given-names></name></person-group>
<article-title>Cell-cycle-dependent subcellular localization of cyclin
B1, phosphorylated cyclin B1 and p34cdc2 during oocyte meiotic maturation and
fertilization in mouse</article-title>. <source>Zygote</source><year>2005</year>;
<volume>13</volume>: <fpage>45</fpage>&#x02013;<lpage>53</lpage>
<pub-id pub-id-type="pmid">15984162</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Huo</surname><given-names>LJ</given-names></name><name><surname>Zhong</surname><given-names>ZS</given-names></name><name><surname>Liang</surname><given-names>CG</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>Ai</surname><given-names>JS</given-names></name><name><surname>Yu</surname><given-names>LZ</given-names></name><name><surname>Chen</surname><given-names>DY</given-names></name><name><surname>Schatten</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>QY</given-names></name></person-group>
<article-title>Degradation of securin in mouse and pig oocytes is
dependent on ubiquitin-proteasome pathway and is required for proteolysis of the
cohesion subunit, Rec8, at the metaphase-to-anaphase transition</article-title>.
<source>Front Biosci</source><year>2006</year>; <volume>11</volume>:
<fpage>2193</fpage>&#x02013;<lpage>2202</lpage>
<pub-id pub-id-type="pmid">16720305</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Evsikov</surname><given-names>AV</given-names></name><name><surname>de Vries</surname><given-names>WN</given-names></name><name><surname>Peaston</surname><given-names>AE</given-names></name><name><surname>Radford</surname><given-names>EE</given-names></name><name><surname>Fancher</surname><given-names>KS</given-names></name><name><surname>Chen</surname><given-names>FH</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Bult</surname><given-names>CJ</given-names></name><name><surname>Latham</surname><given-names>KE</given-names></name><name><surname>Solter</surname><given-names>D</given-names></name><name><surname>Knowles</surname><given-names>BB</given-names></name></person-group>
<article-title>Systems biology of the 2-cell mouse
embryo</article-title>. <source>Cytogenet Genome Res</source><year>2004</year>;
<volume>105</volume>: <fpage>240</fpage>&#x02013;<lpage>250</lpage>
<pub-id pub-id-type="pmid">15237213</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Solter</surname><given-names>D</given-names></name><name><surname>Hiiragi</surname><given-names>T</given-names></name><name><surname>Evsikov</surname><given-names>AV</given-names></name><name><surname>Moyer</surname><given-names>J</given-names></name><name><surname>De Vries</surname><given-names>WN</given-names></name><name><surname>Peaston</surname><given-names>AE</given-names></name><name><surname>Knowles</surname><given-names>BB</given-names></name></person-group>
<article-title>Epigenetic mechanisms in early mammalian
development</article-title>. <source>Cold Spring Harb Symp Quant
Biol</source><year>2004</year>; <volume>69</volume>:
<fpage>11</fpage>&#x02013;<lpage>17</lpage>
<pub-id pub-id-type="pmid">16117628</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Shin</surname><given-names>SW</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Tokoro</surname><given-names>M</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Hatanaka</surname><given-names>Y</given-names></name><name><surname>Anzai</surname><given-names>M</given-names></name><name><surname>Hamazaki</surname><given-names>J</given-names></name><name><surname>Kishigami</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name><name><surname>Murata</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Mouse zygote-specific proteasome assembly chaperone
important for maternal-to-zygotic transition</article-title>. <source>Biol
Open</source><year>2013</year>; <volume>2</volume>:
<fpage>170</fpage>&#x02013;<lpage>182</lpage><pub-id pub-id-type="pmid">23429752</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Suh</surname><given-names>N</given-names></name><name><surname>Blelloch</surname><given-names>R</given-names></name></person-group>
<article-title>Small RNAs in early mammalian development: from gametes to
gastrulation</article-title>. <source>Development</source><year>2011</year>;
<volume>138</volume>: <fpage>1653</fpage>&#x02013;<lpage>1661</lpage>
<pub-id pub-id-type="pmid">21486922</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Goldstrohm</surname><given-names>AC</given-names></name><name><surname>Wickens</surname><given-names>M</given-names></name></person-group>
<article-title>Multifunctional deadenylase complexes diversify mRNA
control</article-title>. <source>Nat Rev Mol Cell Biol</source><year>2008</year>;
<volume>9</volume>: <fpage>337</fpage>&#x02013;<lpage>344</lpage>
<pub-id pub-id-type="pmid">18334997</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Brewer</surname><given-names>G</given-names></name></person-group>
<article-title>The regulation of mRNA stability in mammalian cells:
2.0</article-title>. <source>Gene</source><year>2012</year>; <volume>500</volume>:
<fpage>10</fpage>&#x02013;<lpage>21</lpage>
<pub-id pub-id-type="pmid">22452843</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Radford</surname><given-names>HE</given-names></name><name><surname>Meijer</surname><given-names>HA</given-names></name><name><surname>de Moor</surname><given-names>CH</given-names></name></person-group> Translational control by cytoplasmic polyadenylation in Xenopus oocytes.
<italic>Biochim Biophys Acta</italic><year>2008</year>; <volume>1779</volume>:
<fpage>217</fpage>&#x02013;<lpage>229</lpage></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Semotok</surname><given-names>JL</given-names></name><name><surname>Cooperstock</surname><given-names>RL</given-names></name><name><surname>Pinder</surname><given-names>BD</given-names></name><name><surname>Vari</surname><given-names>HK</given-names></name><name><surname>Lipshitz</surname><given-names>HD</given-names></name><name><surname>Smibert</surname><given-names>CA</given-names></name></person-group>
<article-title>Smaug recruits the CCR4/POP2/NOT deadenylase complex to
trigger maternal transcript localization in the early drosophila embryo</article-title>.
<source>Curr Biol</source><year>2005</year>; <volume>15</volume>:
<fpage>284</fpage>&#x02013;<lpage>294</lpage>
<pub-id pub-id-type="pmid">15723788</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Rouget</surname><given-names>C</given-names></name><name><surname>Papin</surname><given-names>C</given-names></name><name><surname>Boureux</surname><given-names>A</given-names></name><name><surname>Meunier</surname><given-names>AC</given-names></name><name><surname>Franco</surname><given-names>B</given-names></name><name><surname>Robine</surname><given-names>N</given-names></name><name><surname>Lai</surname><given-names>EC</given-names></name><name><surname>Pelisson</surname><given-names>A</given-names></name><name><surname>Simonelig</surname><given-names>M</given-names></name></person-group>
<article-title>Maternal mRNA deadenylation and decay by the piRNA pathway
in the early Drosophila embryo</article-title>.
<source>Nature</source><year>2010</year>; <volume>467</volume>:
<fpage>1128</fpage>&#x02013;<lpage>1132</lpage>
<pub-id pub-id-type="pmid">20953170</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Mizuno</surname><given-names>S</given-names></name><name><surname>Sono</surname><given-names>Y</given-names></name><name><surname>Matsuoka</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Fukuda</surname><given-names>A</given-names></name><name><surname>Morimoto</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name></person-group>
<article-title>Expression and subcellular localization of GSE protein in
germ cells and preimplantation embryos</article-title>. <source>J Reprod
Dev</source><year>2006</year>; <volume>52</volume>:
<fpage>429</fpage>&#x02013;<lpage>438</lpage>
<pub-id pub-id-type="pmid">16571911</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Matsuoka</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Tokoro</surname><given-names>M</given-names></name><name><surname>Shin</surname><given-names>SW</given-names></name><name><surname>Uenoyama</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Hitomi</surname><given-names>S</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Anzai</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Mitani</surname><given-names>T</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Identification of ZAG1, a novel protein expressed in mouse
preimplantation, and its putative roles in zygotic genome activation</article-title>.
<source>J Reprod Dev</source><year>2008</year>; <volume>54</volume>:
<fpage>192</fpage>&#x02013;<lpage>197</lpage>
<pub-id pub-id-type="pmid">18360097</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Baggs</surname><given-names>JE</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name></person-group>
<article-title>Nocturnin, a deadenylase in Xenopus laevis retina: a
mechanism for posttranscriptional control of circadian-related mRNA</article-title>.
<source>Curr Biol</source><year>2003</year>; <volume>13</volume>:
<fpage>189</fpage>&#x02013;<lpage>198</lpage>
<pub-id pub-id-type="pmid">12573214</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Garbarino-Pico</surname><given-names>E</given-names></name><name><surname>Niu</surname><given-names>S</given-names></name><name><surname>Rollag</surname><given-names>MD</given-names></name><name><surname>Strayer</surname><given-names>CA</given-names></name><name><surname>Besharse</surname><given-names>JC</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name></person-group>
<article-title>Immediate early response of the circadian polyA
ribonuclease nocturnin to two extracellular stimuli</article-title>.
<source>RNA</source><year>2007</year>; <volume>13</volume>:
<fpage>745</fpage>&#x02013;<lpage>755</lpage>
<pub-id pub-id-type="pmid">17400819</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Lawitts</surname><given-names>JA</given-names></name><name><surname>Biggers</surname><given-names>JD</given-names></name></person-group> Culture of preimplantation embryos. <italic>Guide to techniques in mouse
development</italic><year>1993</year>; <volume>225</volume>: 153&#x02013;164.</mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Matsushita</surname><given-names>A</given-names></name><name><surname>Hatanaka</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Ishida</surname><given-names>N</given-names></name><name><surname>Anzai</surname><given-names>M</given-names></name><name><surname>Mitani</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Kishigami</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Expression and functional analyses of circadian genes in
mouse oocytes and preimplantation embryos: Cry1 is involved in the meiotic process
independently of circadian clock regulation</article-title>. <source>Biol
Reprod</source><year>2009</year>; <volume>80</volume>:
<fpage>473</fpage>&#x02013;<lpage>483</lpage>
<pub-id pub-id-type="pmid">19020302</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Tokoro</surname><given-names>M</given-names></name><name><surname>Shin</surname><given-names>SW</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>HH</given-names></name><name><surname>Hatanaka</surname><given-names>Y</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Mitani</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Anzai</surname><given-names>M</given-names></name><name><surname>Kishigami</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Deposition of acetylated histones by RNAP II promoter
clearance may occur at onset of zygotic gene activation in preimplantation mouse
embryos</article-title>. <source>J Reprod Dev</source><year>2010</year>;
<volume>56</volume>: <fpage>607</fpage>&#x02013;<lpage>615</lpage>
<pub-id pub-id-type="pmid">20710121</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Stubblefield</surname><given-names>JJ</given-names></name><name><surname>Terrien</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name></person-group>
<article-title>Nocturnin: at the crossroads of clocks and
metabolism</article-title>. <source>Trends Endocrinol Metab</source><year>2012</year>;
<volume>23</volume>: <fpage>326</fpage>&#x02013;<lpage>333</lpage>
<pub-id pub-id-type="pmid">22608110</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Green</surname><given-names>CB</given-names></name><name><surname>Douris</surname><given-names>N</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Strayer</surname><given-names>CA</given-names></name><name><surname>Fogerty</surname><given-names>J</given-names></name><name><surname>Lourim</surname><given-names>D</given-names></name><name><surname>Keller</surname><given-names>SR</given-names></name><name><surname>Besharse</surname><given-names>JC</given-names></name></person-group>
<article-title>Loss of Nocturnin, a circadian deadenylase, confers
resistance to hepatic steatosis and diet-induced obesity</article-title>. <source>Proc
Natl Acad Sci USA</source><year>2007</year>; <volume>104</volume>:
<fpage>9888</fpage>&#x02013;<lpage>9893</lpage>
<pub-id pub-id-type="pmid">17517647</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Dean</surname><given-names>J</given-names></name></person-group>
<article-title>Maternal control of early mouse
development</article-title>. <source>Development</source><year>2010</year>;
<volume>137</volume>: <fpage>859</fpage>&#x02013;<lpage>870</lpage>
<pub-id pub-id-type="pmid">20179092</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Shin</surname><given-names>SW</given-names></name><name><surname>Tokoro</surname><given-names>M</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>HH</given-names></name><name><surname>Hatanaka</surname><given-names>Y</given-names></name><name><surname>Nishihara</surname><given-names>T</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Anzai</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Mitani</surname><given-names>T</given-names></name><name><surname>Kishigami</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Inhibition of the ubiquitin-proteasome system leads to
delay of the onset of ZGA gene expression</article-title>. <source>J Reprod
Dev</source><year>2010</year>; <volume>56</volume>:
<fpage>655</fpage>&#x02013;<lpage>663</lpage>
<pub-id pub-id-type="pmid">20814167</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Tokunaga</surname><given-names>K</given-names></name><name><surname>Kakegawa</surname><given-names>R</given-names></name><name><surname>Yanagisawa</surname><given-names>A</given-names></name><name><surname>Takemoto</surname><given-names>A</given-names></name><name><surname>Tatemizo</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Hatanaka</surname><given-names>Y</given-names></name><name><surname>Matsushita</surname><given-names>A</given-names></name><name><surname>Kishi</surname><given-names>M</given-names></name><name><surname>Anzai</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Mitani</surname><given-names>T</given-names></name><name><surname>Kishigami</surname><given-names>S</given-names></name><name><surname>Saeki</surname><given-names>K</given-names></name><name><surname>Hosoi</surname><given-names>Y</given-names></name><name><surname>Iritani</surname><given-names>A</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<article-title>Expression analysis of circadian genes in oocytes and
preimplantation embryos of cattle and rabbits</article-title>. <source>Anim Reprod
Sci.</source><year>2010</year>; <volume>121</volume>:
<fpage>225</fpage>&#x02013;<lpage>235</lpage>
<pub-id pub-id-type="pmid">20619978</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Osterbur</surname><given-names>DL</given-names></name><name><surname>Megaw</surname><given-names>PL</given-names></name><name><surname>Tosini</surname><given-names>G</given-names></name><name><surname>Fukuhara</surname><given-names>C</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name><name><surname>Besharse</surname><given-names>JC</given-names></name></person-group>
<article-title>Rhythmic expression of Nocturnin mRNA in multiple tissues
of the mouse</article-title>. <source>BMC Dev Biol</source><year>2001</year>;
<volume>1</volume>: <fpage>9</fpage>
<pub-id pub-id-type="pmid">11394964</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name><name><surname>Lecka-Czernik</surname><given-names>B</given-names></name><name><surname>Douris</surname><given-names>N</given-names></name><name><surname>Gilbert</surname><given-names>MR</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Ackert-Bicknell</surname><given-names>C</given-names></name><name><surname>Garg</surname><given-names>N</given-names></name><name><surname>Horowitz</surname><given-names>MC</given-names></name><name><surname>Adamo</surname><given-names>ML</given-names></name><name><surname>Clemmons</surname><given-names>DR</given-names></name><name><surname>Rosen</surname><given-names>CJ</given-names></name></person-group>
<article-title>A circadian-regulated gene, Nocturnin, promotes
adipogenesis by stimulating PPAR-gamma nuclear translocation</article-title>.
<source>Proc Natl Acad Sci USA</source><year>2010</year>; <volume>107</volume>:
<fpage>10508</fpage>&#x02013;<lpage>10513</lpage>
<pub-id pub-id-type="pmid">20498072</pub-id></mixed-citation></ref></ref-list></back></article>